Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
Classification
Class II
Status
Ongoing
Lot
Lot # 23101201 exp 09/2026, 24080801 exp 07/2027, and 25020701 exp 01/2028
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.